Gradient Investments LLC Haleon PLC Transaction History

Gradient Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$7.78 - $8.62 $1,447 - $1,603	-186 Reduced 27.35%	494 $4,000
Q3 2023 Oct 27, 2023	SELL	$7.85 - $8.94 $494 - $563	-63 Reduced 8.48%	680 $5,000
Q2 2023 Jul 11, 2023	BUY	$8.04 - $9.0 $3,023 - $3,384	376 Added 102.45%	743 $6,000
Q1 2023 Apr 17, 2023	SELL	$7.57 - $8.37 $310 - $343	-41 Reduced 10.05%	367 $2,000
Q4 2022 Jan 10, 2023	SELL	$5.96 - $8.06 $989 - $1,337	-166 Reduced 28.92%	408 $0
Q3 2022 Oct 14, 2022	BUY	$5.63 - $7.5 $3,231 - $4,305	574 New	574 $3,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.